Chioma Umeha

BY CHIOMA UMEHA Lagos A recent study from Tel Aviv University suggests a novel AIDS treatment that could be developed into a vaccine or used as a one-time treatment for people living with HIV, giving hope in the long-running search for the Human Immune Virus (HIV).  The research examined altering type B white blood cells in the patient's body to release anti-HIV antibodies in response to the virus, according to a report on Friday confirming the ground-breaking cure.  The study, which was carried out in collaboration with the Sourasky Medical Center (Ichilov), the George S. Wise department of life sciences, and the Dotan Center for Advanced Therapies, was directed by Dr. Adi Barzel and Ph.D. student Alessio Nehmad. Together with other academics from Israel and the United States, the study was conducted. The results were recently published in the esteemed journal Nature Biotechnology.  The use of medications that have changed AIDS from a fatal to a chronic condition has improved the

BY CHIOMA UMEHA Lagos Prostate cancer occurs when abnormal cells in the prostate gland grow uncontrollably, resulting in the formation of a malignant tumor.  Although it is a common form of cancer in men, prostate cancer is very treatable in its early stages. The prostate gland, which is located between the penis and the bladder, is where it starts. The prostate serves a number of purposes. These include releasing PSA, a protein that helps semen maintain its liquid state, producing the fluid that nourishes and transports sperm, and assisting with urine control.  If prostate cancer has spread beyond the prostate gland, it is considered "advanced." It may have spread to nearby tissues, which doctors refer to as "locally advanced." It could also have spread to the lymph nodes, bones, or other parts of the body. Then it is referred to as metastatic prostate cancer. Early prostate cancer frequently has no symptoms, but screening can find changes that might be cancerous.